See more : Seaboard Corporation (SEB) Income Statement Analysis – Financial Results
Complete financial analysis of Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Guizhou Bailing Group Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Shaftesbury Capital PLC (CCPPF) Income Statement Analysis – Financial Results
- Flavor Full Foods Inc. (1260.TWO) Income Statement Analysis – Financial Results
- CPT Drives and Power Public Company Limited (CPT.BK) Income Statement Analysis – Financial Results
- Mida Assets Public Company Limited (MIDA.BK) Income Statement Analysis – Financial Results
- Phoenix Biotech Acquisition Corp. (PBAXW) Income Statement Analysis – Financial Results
Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ)
About Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co., Ltd. researches, develops, produces, and sells Chinese medicines in China. The company provides medicines in the form of tablets, capsules, granules, syrups, pills, powders, tinctures, sprays, and ointments for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases. Guizhou Bailing Group Pharmaceutical Co., Ltd. was founded in 2005 and is based in Anshun, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.26B | 3.54B | 3.11B | 3.09B | 2.85B | 3.14B | 2.59B | 2.21B | 1.90B | 1.57B | 1.41B | 1.37B | 1.14B | 863.76M | 734.52M | 607.36M | 446.20M |
| Cost of Revenue | 1.95B | 1.41B | 1.26B | 1.35B | 1.14B | 1.26B | 951.97M | 788.95M | 720.56M | 616.20M | 559.13M | 622.21M | 508.34M | 412.08M | 397.86M | 323.77M | 229.18M |
| Gross Profit | 2.31B | 2.13B | 1.86B | 1.74B | 1.71B | 1.87B | 1.64B | 1.43B | 1.18B | 958.47M | 846.20M | 745.37M | 630.09M | 451.67M | 336.65M | 283.59M | 217.02M |
| Gross Profit Ratio | 54.19% | 60.12% | 59.62% | 56.44% | 60.12% | 59.75% | 63.27% | 64.37% | 62.06% | 60.87% | 60.21% | 54.50% | 55.35% | 52.29% | 45.83% | 46.69% | 48.64% |
| Research & Development | 42.04M | 22.40M | 30.43M | 37.00M | 24.79M | 30.85M | 37.48M | 24.47M | 21.32M | 16.41M | 8.62M | 6.33M | 3.22M | 2.45M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 82.30M | 78.80M | 59.94M | 78.31M | 60.19M | 46.29M | 43.08M | 39.46M | 38.12M | 43.73M | 25.49M | 30.32M | 23.25M | 22.47M | 40.70M | 39.19M | 24.83M |
| Selling & Marketing | 1.91B | 1.53B | 1.29B | 1.14B | 970.36M | 933.13M | 782.34M | 613.80M | 456.90M | 392.51M | 362.53M | 354.46M | 262.23M | 192.05M | 144.21M | 123.43M | 91.26M |
| SG&A | 2.63B | 1.61B | 1.35B | 1.21B | 1.03B | 979.42M | 825.43M | 653.26M | 495.02M | 436.24M | 388.03M | 384.78M | 285.48M | 214.52M | 184.90M | 162.61M | 116.09M |
| Other Expenses | 120.82M | 173.12M | 164.12M | 156.22M | 148.60M | 1.57M | -6.22M | 10.40M | 21.58M | 5.79M | 6.65M | 36.77M | 3.75M | 22.33M | 652.85K | -1.75M | 1.09M |
| Operating Expenses | 2.79B | 1.80B | 1.54B | 1.41B | 1.20B | 1.16B | 979.50M | 818.31M | 648.46M | 547.96M | 481.80M | 460.00M | 345.78M | 249.24M | 192.14M | 168.48M | 120.50M |
| Cost & Expenses | 4.75B | 3.22B | 2.80B | 2.75B | 2.34B | 2.42B | 1.93B | 1.61B | 1.37B | 1.16B | 1.04B | 1.08B | 854.12M | 661.32M | 590.00M | 492.25M | 349.68M |
| Interest Income | 6.12M | 2.24M | 1.30M | 66.94M | 57.23M | 33.26M | 7.88M | 5.37M | 14.23M | 12.11M | 10.20M | 53.55M | 26.60M | 10.61M | 75.83K | 100.24K | -0.09 |
| Interest Expense | 86.85M | 101.66M | 113.81M | 131.31M | 111.16M | 48.53M | 1.21M | 21.81M | 29.74M | 47.32M | 51.21M | 80.29M | 69.03M | 26.36M | 13.32M | 15.19M | 8.95M |
| Depreciation & Amortization | 116.66M | 123.49M | 113.78M | 117.04M | 97.84M | 85.61M | 73.23M | 79.57M | 70.87M | 63.98M | 48.27M | 44.87M | 28.25M | 13.75M | 13.51M | 13.19M | 12.40M |
| EBITDA | -298.61M | 370.05M | 353.41M | 412.70M | 548.39M | 757.86M | 706.84M | 663.62M | 563.64M | 462.05M | 404.93M | 324.40M | 288.36M | 210.46M | 158.29M | 125.22M | 108.92M |
| EBITDA Ratio | -7.00% | 13.39% | 12.37% | 16.69% | 20.41% | 27.12% | 28.45% | 31.62% | 33.81% | 31.82% | 30.87% | 28.77% | 30.20% | 26.99% | 21.66% | 20.85% | 24.63% |
| Operating Income | -484.42M | 357.96M | 277.90M | 418.79M | 493.25M | 664.25M | 626.42M | 569.90M | 470.63M | 371.53M | 319.90M | 253.74M | 238.32M | 183.23M | 130.81M | 99.41M | 86.40M |
| Operating Income Ratio | -11.36% | 10.11% | 8.93% | 13.56% | 17.30% | 21.18% | 24.17% | 25.74% | 24.78% | 23.59% | 22.76% | 18.55% | 20.93% | 21.21% | 17.81% | 16.37% | 19.36% |
| Total Other Income/Expenses | -8.65M | -198.91M | -26.98M | -210.02M | -137.51M | 1.57M | 5.79M | 10.35M | 21.26M | 5.58M | 6.26M | -17.28M | -37.92M | -9.54M | -12.18M | -17.43M | -7.98M |
| Income Before Tax | -493.07M | 159.06M | 147.76M | 208.77M | 355.75M | 665.82M | 632.20M | 579.94M | 491.90M | 377.11M | 326.16M | 263.38M | 241.97M | 189.56M | 131.45M | 96.84M | 87.49M |
| Income Before Tax Ratio | -11.57% | 4.49% | 4.75% | 6.76% | 12.48% | 21.23% | 24.39% | 26.19% | 25.90% | 23.95% | 23.21% | 19.26% | 21.25% | 21.95% | 17.90% | 15.94% | 19.61% |
| Income Tax Expense | -80.61M | 23.09M | 31.07M | 55.04M | 71.20M | 94.06M | 100.17M | 93.68M | 75.75M | 62.05M | 53.17M | 34.52M | 31.99M | 31.36M | 19.78M | 16.54M | 15.49M |
| Net Income | -414.51M | 138.47M | 118.48M | 152.38M | 282.75M | 563.24M | 526.14M | 482.33M | 411.37M | 310.48M | 269.60M | 221.75M | 208.38M | 158.20M | 111.67M | 80.30M | 71.91M |
| Net Income Ratio | -9.72% | 3.91% | 3.81% | 4.93% | 9.92% | 17.96% | 20.30% | 21.78% | 21.66% | 19.72% | 19.18% | 16.21% | 18.30% | 18.32% | 15.20% | 13.22% | 16.11% |
| EPS | -0.30 | 0.10 | 0.08 | 0.11 | 0.20 | 0.40 | 0.37 | 0.34 | 0.29 | 0.22 | 0.19 | 0.16 | 0.15 | 0.13 | 0.17 | 0.08 | 0.07 |
| EPS Diluted | -0.30 | 0.10 | 0.08 | 0.11 | 0.20 | 0.39 | 0.37 | 0.34 | 0.29 | 0.22 | 0.19 | 0.16 | 0.15 | 0.12 | 0.17 | 0.08 | 0.07 |
| Weighted Avg Shares Out | 1.38B | 1.40B | 1.40B | 1.41B | 1.41B | 1.41B | 1.41B | 1.41B | 1.41B | 1.41B | 1.42B | 1.42B | 1.42B | 1.25B | 656.86M | 1.06B | 1.06B |
| Weighted Avg Shares Out (Dil) | 1.38B | 1.40B | 1.40B | 1.41B | 1.41B | 1.44B | 1.42B | 1.42B | 1.42B | 1.41B | 1.42B | 1.42B | 1.42B | 1.28B | 656.86M | 1.06B | 1.06B |
No news found for: 002424.SZ
Source: https://incomestatements.info
Category: Stock Reports